Menu
Enrolling by invitation NCT07171957

Motor Imagery in Chronic Obstructive Pulmonary Disease

Observational Chronic Obstructive Pulmonary Disease (COPD) Mental Imagery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Obstructive Pulmonary Disease (COPD), Mental Imagery. Basic parameters: 40 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of Motor Imagery in Individuals With Chronic Obstructive Pulmonary Disease

Overview

The purpose of this study was to compare the motor imagery ability of individuals with Chronic Obstructive Pulmonary Disease (COPD) with those without COPD.

Detailed description

The study will begin after receiving approval from the KSBU Non-Interventional Ethics Committee for its compliance. Before data collection begins, each participant who agrees to the study will be informed about the study, and will be asked to sign a voluntary consent form. After obtaining demographic and disease-specific information, participants will be divided into two groups: COPD and non-COPD individuals, and their cognitive skills, dominant hand preference, and motor imagery abilities will be assessed. The cognitive functions of all participants will be assessed using the Standardized Mini Mental State Examination. Participants will be included in the study if they score ≥24. The dominant hand preference of the participants will be determined using the Edinburgh Hand Preference Questionnaire and recorded on the assessment form. In the tests and surveys to be conducted, the dominant hand will be determined based on the results of this questionnaire, and the results of tests performed with the dominant side will be recorded. The GOLD ABE Assessment Tool will be used to assess COPD patients. As part of the GOLD ABE Assessment Tool, patients' pulmonary function test results, COPD Assessment Test (CAT) results, Modified Health Research Council Dyspnoea Scale (mMRC) results, exacerbation history, and hospitalization history will be recorded. Oxygen saturation values of COPD patients will be recorded. Routine measurement results for oxygen saturation and pulmonary function test values of individuals with COPD will be recorded. Participants' motor imagery skills will be assessed using the Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20). The Nine-Hole Peg Test will be used to assess the temporal correspondence between participants' actual and imagined movement (mental chronometry). Temporal correspondence between actual and imagined movement will be calculated using the formula. Participants' mental rotation abilities will be assessed using the hand laterality test (hand identification test), one of the mental rotation subcomponents, using the Recognise Hand mobile application. Data obtained from individuals with COPD and individuals without COPD will be recorded. Based on the data obtained, the motor imagery abilities of the two groups will be compared using appropriate statistical methods. The correlation between the disease-specific knowledge of individuals in the COPD group and their motor imagery abilities will be calculated.

Primary outcome measures

  • Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20) [Time frame: Baseline (First assessment)]
Secondary outcome measures (2)
  • Mental Chronometry Test [Time frame: Baseline (First assessment)]
  • Mental Rotation Test [Time frame: Baseline (First assessment)]

Eligibility criteria

Inclusion criteria

  • Being between 40-70 years of age
  • Being diagnosed with COPD
  • Having 24 points or more on the Mini Mental State Examination
  • Not having a history of acute exacerbation and/or hospitalization in the last month and being clinically stable

Exclusion criteria

  • Being between 40-70 years old
  • Having a score of 24 or above on the Mini Mental State Examination
  • Not having any pulmonary, cardiac, orthopedic or neurological disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Kütahya Health Sciences University — Kütahya

Identifiers

NCT: NCT07171957 · 2025/07-09

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗